A detailed history of Quest Partners LLC transactions in Viatris Inc stock. As of the latest transaction made, Quest Partners LLC holds 41,449 shares of VTRS stock, worth $444,333. This represents 0.03% of its overall portfolio holdings.

Number of Shares
41,449
Previous 41,543 0.23%
Holding current value
$444,333
Previous $371 Million 10.61%
% of portfolio
0.03%
Previous 0.04%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 03, 2025

SELL
$8.74 - $10.69 $821 - $1,004
-94 Reduced 0.23%
41,449 $410 Million
Q2 2025

Jul 31, 2025

BUY
$7.26 - $9.12 $254,143 - $319,254
35,006 Added 535.51%
41,543 $371 Million
Q1 2025

May 14, 2025

BUY
$8.68 - $12.42 $5,294 - $7,576
610 Added 10.29%
6,537 $56.9 Million
Q4 2024

Feb 07, 2025

SELL
$11.32 - $13.37 $150,182 - $177,379
-13,267 Reduced 69.12%
5,927 $73.8 Million
Q3 2024

Nov 07, 2024

BUY
$10.32 - $12.13 $198,082 - $232,823
19,194 New
19,194 $223 Million
Q1 2024

May 09, 2024

BUY
$11.27 - $13.53 $529 - $635
47 New
47 $561,000

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $13B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Quest Partners LLC Portfolio

Follow Quest Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quest Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quest Partners LLC with notifications on news.